Skip to main content

Table 3 Grade 3 or 4 drug related adverse events

From: Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I131KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma

Event Intra-arterial
(n = 9)
Intra-venous
(n = 9)
Total
(n = 18)
Lymphopenia 3 2 5
Thrombocytopenia 4 2 6
Leukopenia 4 0 4
Neutropenia 3 0 3
Sepsis 1 1 2
Vomiting 1 1 2
Alanine aminotransferase 1 0 1
Anaemia 0 1 1
Anorexia 0 1 1
Aspartate aminotransferase 1 0 1
Blood alkaline phosphatase 1 0 1
Febrile neutropenia 1 0 1
Haematemesis 0 1 1
Neutrophilia 1 0 1
Thrombosis 1 0 1